Collecting and assessing reports of adverse events or side effects associated with medications from various sources, including healthcare professionals, patients, and clinical trials.

Monitoring and evaluating safety data throughout all phases of clinical trials to identify and address potential risks or adverse reactions related to investigational drugs.

Employing methodologies and tools to identify potential signals or patterns in data that may indicate previously unrecognized risks associated with specific drugs or classes of drugs.

Assessing the seriousness and potential impact of reported adverse events on patient safety, and conducting thorough evaluations to determine causality and risk factors.

Ensuring compliance with regulatory requirements for pharmacovigilance, including timely reporting of adverse events to regulatory authorities in accordance with specific guidelines.

Continuously monitoring the safety profile of approved drugs once they are on the market to identify and address any emerging safety concerns or new adverse effects.

Establishing and maintaining robust pharmacovigilance systems and databases to collect, manage, and analyze safety information efficiently.

Providing education and training to healthcare professionals, researchers, and the public about pharmacovigilance principles, reporting mechanisms, and the importance of drug safety.

Implementing measures to continuously improve pharmacovigilance processes, such as enhancing reporting systems, adopting new technologies, and refining risk assessment methodologies.